ALS Global capabilities (Pharmaceutical)

Importance of the Topic

High-quality analytical testing underpins pharmaceutical development, manufacturing and regulatory compliance. A global laboratory network capable of delivering consistent, validated results is essential for ensuring drug safety, efficacy and adherence to international standards. Robust analytical services also support supply chain transparency and accelerate time-to-market for new drugs.

Study Aims and Overview

This document profiles ALS, a leading global testing, inspection and certification (TIC) company with over 40 years in operation. The overview highlights the company’s reach, operational scale and core values. It then details ALS’s pharmaceutical services, covering chemistry, microbiology, stability, water testing and quality management. The goal is to demonstrate ALS’s capability to meet diverse client needs through advanced instrumentation, rigorous methods and global consistency.

Methodology and Instrumentation

ALS employs standardized methods aligned with major pharmacopoeias (USP, Ph. Eur., BP, JP, ICH) and local regulations. Key analytical areas include:

• Chemical analysis: HPLC (UV-Vis, PDA, RI, fluorescence), GC (FID, TCD, MS), LC-MS, ICP-MS, ICP-OES, ICP-SFMS, AAS, FTIR, TOC, Karl Fischer titration and conductivity.
• Microbiology: Total viable counts, yeast and mold, specific pathogens, endotoxin (LAL), sterility, preservative efficacy, disinfectant efficacy, microbial identification by DNA sequencing and environmental monitoring (air, surface, water).
• Stability studies: ICH-compliant storage chambers (−84 °C to 50 °C under defined humidity), photostability testing per Q1B, real-time monitoring with 21 CFR Part 11–compliant data loggers.
• Water testing: Purified water, water for injection, steam-sterilizer condensate, according to CFPP, EN, HTM and USP chapters with complete chemical and microbiological profiling.

Project workflows include test method development, validation (ICH Q2/R1), method transfer, routine QC and stability testing. All laboratories operate under GLP, GMP and ISO 17025 frameworks and undergo frequent audits by regulatory bodies and clients.

Main Results and Discussion

ALS maintains over 350 locations in more than 65 countries, serving government agencies, multinational corporations, manufacturers and retailers. Key performance indicators include 40 million samples per year, global revenue exceeding USD 1.6 billion and strong Health, Safety & Environment (HSE) metrics (LTIFR and TRIFR improvements, PPI score > 90%). The company’s integrated safety culture and environmental stewardship ensure consistent risk management across regions.

Pharmaceutical service lines demonstrate high throughput and flexibility: batch release testing for tablets, capsules, injectables, topical and liquid formulations; bespoke method validation and transfer; comprehensive elemental impurity screening under ICH Q3D, USP <232>/<233> and Ph. Eur. 2.4.20; and full microbiological support from bioburden to endotoxin and environmental monitoring.

Benefits and Practical Applications

Clients benefit from:

• Global coverage with local expertise and market-specific knowledge.
• Access to emerging technology, technical experts and centralized LIMS with secure electronic data delivery (Webtrieve™).
• Regulatory compliance support for GMP, GLP and pharmacopoeial requirements.
• Value-added services such as chain-of-custody protocols, customized electronic data delivery formats, client portals and mobile access.
• Optional laboratory tours, technical bulletins and proactive client training.

Future Trends and Applications

Emerging directions include:

• Greater automation and robotics for sample preparation and high-throughput screening.
• Integration of advanced mass spectrometry techniques (e.g., HR-MS) for impurity profiling and metabolomics.
• Digital transformation through cloud-based LIMS, AI-driven data analytics and remote monitoring.
• Enhanced green analytical approaches to minimize solvent use and waste.
• Continued expansion of global network to support localized regulatory changes and accelerated drug development.

Conclusion

ALS offers a comprehensive suite of pharmaceutical analytical services supported by a global network, state-of-the-art instrumentation and rigorous quality systems. Its integrated approach to safety, compliance and client service positions the company as a strategic partner for pharmaceutical manufacturers worldwide.

Instrumentation Used

Major analytical platforms include:

• HPLC with UV-Vis, PDA, RI and fluorescence detectors.
• GC with FID, TCD and MS detectors; GC-MS.
• LC-MS and high-resolution ICP-MS (ICP-SFMS).
• ICP-OES, atomic absorption spectrophotometers.
• FTIR spectrometer, UV/VIS spectrophotometer, total organic carbon analyzer.
• Karl Fischer moisture titrator, auto-titrator, dissolution testers, photostability chambers.
• Laboratory Information Management System (LIMS) compliant with 21 CFR Part 11.